Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Celladon Corp | 142,500 | reported | 01 Jan 2015 | tx 2+137,000 |
| Travere Therapeutics, Inc. | 105,211 | reported | 06 May 2026 | tx 116+866,599−246,673 |
| ANADYS PHARMACEUTICALS INC | 50,000 | reported | 20 Jan 2011 | tx 26+530,988−9,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 May 2026 | EXERCISE | Travere Therapeutics, Inc. | 20,000 | 17.96 USD | 10b5-1 |
| 04 May 2026 | SALE | Travere Therapeutics, Inc. | 20,000 | 45.00 USD | 10b5-1 |
| 04 May 2026 | EXERCISE | Travere Therapeutics, Inc. | 4,250 | 0.00 USD | 10b5-1 |
| 05 May 2026 | SALE | Travere Therapeutics, Inc. | 2,174 | 46.65 USD | 10b5-1 |
| 06 May 2026 | SALE | Travere Therapeutics, Inc. | 2,076 | 43.95 USD | 10b5-1 |
| 04 May 2026 | EXERCISE | Travere Therapeutics, Inc. | 20,000 | 0.00 USD | 10b5-1deriv |
| 04 May 2026 | GRANT_AWARD | Travere Therapeutics, Inc. | 8,500 | 0.00 USD | 10b5-1deriv |
| 04 May 2026 | EXERCISE | Travere Therapeutics, Inc. | 4,250 | 0.00 USD | 10b5-1deriv |
| 16 Mar 2026 | EXERCISE | Travere Therapeutics, Inc. | 10,000 | 19.08 USD | |
| 16 Mar 2026 | SALE | Travere Therapeutics, Inc. | 10,000 | 28.09 USD | |
| 16 Mar 2026 | EXERCISE | Travere Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 17 Feb 2026 | SALE | Travere Therapeutics, Inc. | 4,321 | 28.26 USD | |
| 17 Feb 2026 | EXERCISE | Travere Therapeutics, Inc. | 10,000 | 19.08 USD | |
| 17 Feb 2026 | SALE | Travere Therapeutics, Inc. | 5,679 | 27.50 USD | |
| 17 Feb 2026 | EXERCISE | Travere Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 04 Feb 2026 | SALE | Travere Therapeutics, Inc. | 509 | 32.74 USD | |
| 04 Feb 2026 | SALE | Travere Therapeutics, Inc. | 2,485 | 32.07 USD | |
| 31 Jan 2026 | GRANT_AWARD | Travere Therapeutics, Inc. | 25,110 | 0.00 USD | |
| 03 Feb 2026 | SALE | Travere Therapeutics, Inc. | 7,175 | 32.12 USD | |
| 31 Jan 2026 | GRANT_AWARD | Travere Therapeutics, Inc. | 66,960 | 0.00 USD | deriv |
| 20 Jan 2026 | SALE | Travere Therapeutics, Inc. | 10,000 | 27.34 USD | |
| 20 Jan 2026 | EXERCISE | Travere Therapeutics, Inc. | 10,000 | 19.08 USD | |
| 20 Jan 2026 | EXERCISE | Travere Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 22 Sept 2025 | SALE | Travere Therapeutics, Inc. | 10,000 | 25.00 USD | |
| 22 Sept 2025 | EXERCISE | Travere Therapeutics, Inc. | 10,000 | 19.08 USD |